Filter
761
Text search:
Beta
Featured
Recommendations
92
New Publications
141
Language
Document type
No document type
282
Guidelines
205
Studies & Reports
164
Manuals
40
Fact sheets
32
Strategic & Response Plan
18
Situation Updates
9
Training Material
4
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
India
55
Global
38
South Africa
25
Indonesia
20
Brazil
20
Latin America and the Carribbean
19
Kenya
17
Africa
17
Ethiopia
16
Philippines
13
Germany
12
Nepal
10
Ghana
8
Western and Central Europe
7
Paraguay
7
Tanzania
6
Argentina
6
Venezuela
6
Nigeria
5
Uganda
5
Rwanda
5
Malawi
5
Mozambique
5
Ukraine
5
Colombia
5
Sierra Leone
4
Zimbabwe
4
Peru
4
Ecuador
4
Bolivia
4
Cameroon
3
Pakistan
3
Namibia
3
Eswatini/ Swaziland
3
Angola
3
Chile
3
East and Southern Africa
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Russia
3
Spain
3
Burkina Faso
2
Liberia
2
Congo, Democratic Republic of
2
South Sudan
2
Zambia
2
Bangladesh
2
Papua New Guinea
2
North Macedonia
2
El Salvador
2
Libya
2
Lesotho
2
Myanmar / Burma
2
Western Pacific Region
2
Armenia
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
Vietnam
2
Belarus
2
Senegal
1
Mali
1
Guinea-Bissau
1
USA
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Egypt
1
Chad
1
Cambodia
1
Thailand
1
Benin
1
Central African Republic
1
Serbia
1
Honduras
1
Botswana
1
Madagascar
1
South–East Asia Region
1
Fiji
1
Bhutan
1
Eastern Europe
1
Italy
1
Mongolia
1
Laos
1
Tajikistan
1
Uzbekistan
1
Gabon
1
Uruguay
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
315
Clinical Guidelines
80
Public Health
58
Women & Child Health
22
Key Resources
11
Pharmacy & Technologies
10
Capacity Building
2
Toolboxes
AMR
133
COVID-19
113
NCDs
66
Mental Health
54
Pharmacy
38
Planetary Health
23
HIV
16
Specific Hazards
16
Caregiver
13
TB
12
Conflict
8
NTDs
8
Global Health Education
7
Ebola
5
Rapid Response
5
Refugee
5
Natural Hazards
4
Health Financing Toolbox
3
Disability
2
Cholera
1
Zika
1
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance.
T
...
Stand 2.10.2020
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,
...
16.7.2021
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib
...
Given an increase in outbreaks caused by resistant microorganisms associated with medical tourism, the Pan American Health Organization / World Health Organization (PAHO/WHO) encourages Member States to strengthen their capacity to detect and manage infections caused by resis
...
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th
...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re
...
Le HCSP a fondé ses recommandations sur les connaissances actuellement disponibles en particulier les publications scientifiques relatives au COVID-19 mais aussi de recommandations relatives à la prise en charge des pneumonies post grippales, et des pneumonies sévères en réanimation.
Cet avi
...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe
...
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By
...
Volume 2019, Article ID 4157574, 7 pages
https://doi.org/10.1155/2019/4157574
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I
...
Lancet. 2019; 394: 1212-1214
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
This guidance covers diagnosis and care of patients with long-term effects of COVID-19. It makes recommendations for the care of adults and children who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It is meant for health and care practitioners. This interim documen
...